Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pravastatin versus placebo for prevention of pre-eclampsia in high-risk pregnancy
ISRCTN17787139Phase 3Terminated
- Sponsor
- Fundación para la Formación e Investigación Sanitaria
- Start
- Mar 2016
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of pravastatin in preeclampsia, sponsored by Fundación para la Formación e Investigación Sanitaria. Primary endpoint: Incidence of preterm pre-eclampsia before 37 weeks. Started Mar 2016; status: terminated.
02
Drugs
pravastatin
03
Conditions
preeclampsia
Beyond the preview
Go deeper on ISRCTN17787139.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN17787139.